Table 1_Case Report: Ruxolitinib for systemic juvenile idiopathic arthritis complicated by

Two pediatric case reports detail the use of ruxolitinib for refractory systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome. The document includes a literature review summarizing outcomes for a total of seven pediatric patients. Authored by Honglin Liu and shared under a CC-BY-4.0 license, the file was last updated on 2026-05-28.

Use Cases

• Analyzing treatment efficacy based on clinical symptom improvement and glucocorticoid tapering timelines described in the cases.
• Reviewing safety profiles based on reported adverse events like cytopenia and viral infections.
• Summarizing patient demographics and outcomes from the aggregated literature review of seven pediatric cases.

Strengths

• Includes detailed clinical timelines for two specific pediatric cases.
• Aggregates data from a literature review covering seven total patients with age and gender breakdowns.
• Explicitly documents the absence of ruxolitinib-related adverse events in the reported center cases.

Limitations

• Data is contained within a 15.9 KB document, indicating a very limited scope and scale.
• Description metadata is limited; actual data quality requires manual inspection after download.
• Column-level documentation is absent; field semantics must be inferred after download.

Provenance

Source

figshare

Collection Method

Retrospective case review and literature synthesis.

Freshness

Last updated 2026-05-28 06:20:03; freshness should be verified.